Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients
- PMID: 22965366
- PMCID: PMC10619953
- DOI: 10.1590/s1516-31802012000400008
Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients
Abstract
Context and objective: Hemoglobin (Hb) D hemoglobinopathies are widespread diseases in northwestern India and usually present with mild hemolytic anemia and mild to moderate splenomegaly. The heterozygous form of Hb D is clinically silent, but coinheritance of Hb D with Hb S or beta-thalassemia produces clinically significant conditions like thalassemia intermedia of moderate severity. Under heterozygous conditions with coinheritance of alpha and beta-thalassemia, patients show a degree of clinical variability. Thus, our aim was to molecularly characterize the Hb D trait among individuals who were clinically symptomatic because of co-inheritance of alpha deletions or any beta-globin gene mutations.
Design and setting: This was a cross-sectional study conducted in an autonomous tertiary-care hospital.
Methods: Complete blood count and red cell indices were measured using an automated cell analyzer. Quantitative assessment of hemoglobin Hb F, Hb A, Hb A2 and Hb D was performed by means of high performance liquid chromatography (HPLC). DNA extraction was done using the phenol-chloroform method. Molecular analyses on common alpha deletions and common beta mutations were done using the Gap polymerase chain reaction and Amplification Refractory Mutation System, respectively.
Results: We evaluated 30 patients and found clinical variation in the behavior of Hb D traits. In six patients, the Hb D traits were clinically symptomatic and behaved like those of thalassemia intermedia. Molecular characterization showed that three out of these six were IVS-1-5 positive.
Conclusions: HPLC may not be the gold standard for diagnosing symptomatic Hb D Punjab traits. Hence, standard confirmation should include molecular studies.
CONTEXTO E OBJETIVO:: Hemoglobinopatias da hemoglobina (Hb) D são doenças amplamente disseminadas no noroeste da Índia e geralmente se apresentam com anemia hemolítica leve e esplenomegalia leve a moderada. A forma heterozigótica de Hb D é clinicamente silenciosa, mas co-herança de Hb D com Hb S ou beta-talassemia produzem condições clinicamente significativas, como talassemia intermediária de gravidade moderada. Em condição heterozigótica com co-herança de alfa e beta-talassemia, pacientes mostram variabilidade clínica. Assim, nosso objetivo foi a caracterização molecular dos traços da Hb D em individuos clinicamente sintomáticos, devido à co-herança de deleções de alfa ou quaisquer mutações gênicas de beta-globina.
TIPO DE ESTUDO E LOCAL:: Estudo transversal; realizado em um hospital de cuidado terciário autônomo.
MÉTODOS:: Hemograma completo e índices de células vermelhas foram medidos pelo analisador automatizado de células. Avaliação quantitativa de hemoglobina Hb F, Hb A, Hb A2 e Hb D foi realizada por cromatografia líquida de alta eficiência. Extração de DNA foi feita pelo método de fenol-clorofórmio. Estudo molecular para deleções comuns de alfa e mutações comuns de beta foi feito por Gap-reação em cadeia da polimerase e amplificação refratária de mutação, respectivamente.
RESULTADOS:: Avaliamos 30 pacientes e verificamos variação clínica no comportamento dos traços da Hb D. Em seis pacientes, os traços da Hb D foram clinicamente sintomáticos e se comportavam como os de talassemia intermédia. A caracterização molecular mostrou que três desses seis pacientes eram IVS-1-5 positivos.
CONCLUSÕES:: HPLC pode não ser o padrão ouro para o diagnóstico de traços de Hb D Punjab sintomáticos. Assim, a confirmação padrão ouro deve incluir estudos moleculares.
Conflict of interest statement
Figures
Similar articles
-
[Analysis of hematological phenotype and genotype of 23 patients from Guangdong with co-inherited hemoglobin Hb Westmead and β-thalassemia].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):598-601. doi: 10.3760/cma.j.issn.1003-9406.2016.05.003. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016. PMID: 27577202 Chinese.
-
A novel double heterozygous Hb Fontainebleau/HbD Punjab hemoglobinopathy.Clin Biochem. 2015 Sep;48(13-14):904-7. doi: 10.1016/j.clinbiochem.2015.05.020. Epub 2015 May 31. Clin Biochem. 2015. PMID: 26036869
-
Clinicohematological and molecular analysis of hemoglobin D syndrome and unknown variants in the hemoglobinopathy spectrum of Sindh, Pakistan.PLoS One. 2025 May 15;20(5):e0320354. doi: 10.1371/journal.pone.0320354. eCollection 2025. PLoS One. 2025. PMID: 40373022 Free PMC article.
-
Laboratory investigation of hemoglobinopathies and thalassemias: review and update.Clin Chem. 2000 Aug;46(8 Pt 2):1284-90. Clin Chem. 2000. PMID: 10926923 Review.
-
[The association of beta zero-thalassemia and Hb D Punjab in a family of Indian origin. The second case reported in Spain].Med Clin (Barc). 1997 Mar 15;108(10):385-8. Med Clin (Barc). 1997. PMID: 9139146 Review. Spanish.
Cited by
-
Double heterozygous hemoglobin Q India/hemoglobin D Punjab hemoglobinopathy: Report of two rare cases.Indian J Hum Genet. 2013 Oct;19(4):479-82. doi: 10.4103/0971-6866.124381. Indian J Hum Genet. 2013. PMID: 24497718 Free PMC article.
-
Detection of Abnormal Hemoglobin Variants by HPLC Method: Common Problems with Suggested Solutions.Int Sch Res Notices. 2014 Oct 12;2014:257805. doi: 10.1155/2014/257805. eCollection 2014. Int Sch Res Notices. 2014. Retraction in: Int Sch Res Notices. 2015 Apr 16;2015:498230. doi: 10.1155/2015/498230. PMID: 27351019 Free PMC article. Retracted.
-
Low serum haptoglobin and blood films suggest intravascular hemolysis contributes to severe anemia in hereditary hemorrhagic telangiectasia.Haematologica. 2019 Apr;104(4):e127-e130. doi: 10.3324/haematol.2018.205682. Epub 2018 Oct 18. Haematologica. 2019. PMID: 30337360 Free PMC article. No abstract available.
-
Hemoglobin Variants as Targets for Stabilizing Drugs.Molecules. 2025 Jan 17;30(2):385. doi: 10.3390/molecules30020385. Molecules. 2025. PMID: 39860253 Free PMC article. Review.
-
Unveiling Rare Hemoglobinopathies: Hematologic Characterization of Double Heterozygous Hb D and Hb E With Beta-Thalassemia-A Case Report.Case Rep Hematol. 2025 Jul 6;2025:8375604. doi: 10.1155/crh/8375604. eCollection 2025. Case Rep Hematol. 2025. PMID: 40661155 Free PMC article.
References
-
- Lukens JN. The Abnormal Hemoglobins: General Principles. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, editors. Wintrobe's Clinical Hematology. 10. Baltimore: Lippincott Williams & Wilkins; 1998. pp. 1329–1345.
-
- Ozsoylu S. Homozygous hemoglobin D Punjab. Acta Haematol. 1970;43(6):353–359. - PubMed
-
- Li HJ, Zhao XN, Qin F. Abnormal hemoglobins in the Silk Road region of China. Hum Genet. 1990;86(2):231–235. - PubMed
-
- Fioretti G, De Angioletti M, Pagano L. DNA polymorphisms associated with Hb D-Los Angeles [beta 121(GH4)Glu-->Gln] in southern Italy. Hemoglobin. 1993;17(1):9–17. - PubMed
-
- Husquinet H, Parent MT, Schoos-Barbette S. Hemoglobin D-Los Angeles [beta 121(GH4)Glu----Gln] in the Province of Liège, Belgium. Hemoglobin. 1986;10(6):587–592. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous